HLA-A and cancer: The target peptides of such reagents have typically derived from either viral antigens (including HIV and Hepatitis B antigens) or cancer antigens, and they are commonly presented by either the HLA-A*0201 or the HLA-A*2402 MHC-I haplotype (61, 62).